Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57).

By A. Wright, A. Burden, R. Paisey, C. Cull, Rury R. Holman. Diabetes Care, 2002

614 citations recorded by the source corpus.

Subfields: Endocrinology, Diabetes and Metabolism

View Paper: https://www.semanticscholar.org/paper/40ae7a93163569359c2a056c97267ce66a78819c

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. Alan J. Garber
2. Martin J. Abrahamson
3. Joshua I. Barzilay
4. Lawrence Blonde
5. Zachary T. Bloomgarden
6. Michael A. Bush
7. S. Dagogo-Jack
8. Ralph A. DeFronzo

Citations in the corpus

• Barriers to diabetes management: patient and provider factors. (2011, neutral): “[18].”
• CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM--2016 EXECUTIVE SUMMARY. (2016, background): “There are no specific approvals for the use of SFUs with insulin, but when they are used together the risks of both weight gain and hypoglycemia increase (141,142).”